Search research articles
Contact Us
Filters
Showing results (541-550 of 558) with videos related to
Page
of 56
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer
Angela K Green, Qin Zhou, Alexia Iasonos, et al.
Msystems
|
June 1, 2021
Transcriptional Regulation of Plant Biomass Degradation and Carbohydrate Utilization Genes in the Extreme Thermophile <i>Caldicellulosiruptor bescii</i>
Dmitry A Rodionov, Irina A Rodionova, Vladimir A Rodionov, et al.
Gynecologic Oncology
|
November 24, 2019
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer
Marina Stasenko, Irina Tunnage, Charles W Ashley, et al.
Blood Advances
|
February 24, 2026
Feasibility of Decentralized Real-World Monitoring of SARS-CoV-2 Booster Vaccines and COVID-19 Outcomes in Myeloma
William A Wood, Shaji K Kumar, Emily Semmel, et al.
JAMA Oncology
|
June 17, 2021
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial Cancer
Maria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2022
Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles
Beryl L Manning-Geist, Ying L Liu, Kelly A Devereaux, et al.
Journal for Immunotherapy of Cancer
|
June 13, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
Sujana Movva, Kenneth Seier, Martina Bradic, et al.
Nature Medicine
|
April 23, 2024
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Claire F Friedman, Beryl L Manning-Geist, Qin Zhou, et al.
Scientific Reports
|
October 17, 2020
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis
Xuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, et al.
Page
of 56
Search research articles
Search
Showing results (541-550 of 558) with videos related to
Sort By:
Page
of 56
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer
Angela K Green, Qin Zhou, Alexia Iasonos, et al.
Msystems
|
June 1, 2021
Transcriptional Regulation of Plant Biomass Degradation and Carbohydrate Utilization Genes in the Extreme Thermophile <i>Caldicellulosiruptor bescii</i>
Dmitry A Rodionov, Irina A Rodionova, Vladimir A Rodionov, et al.
Gynecologic Oncology
|
November 24, 2019
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer
Marina Stasenko, Irina Tunnage, Charles W Ashley, et al.
Blood Advances
|
February 24, 2026
Feasibility of Decentralized Real-World Monitoring of SARS-CoV-2 Booster Vaccines and COVID-19 Outcomes in Myeloma
William A Wood, Shaji K Kumar, Emily Semmel, et al.
JAMA Oncology
|
June 17, 2021
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial Cancer
Maria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2022
Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles
Beryl L Manning-Geist, Ying L Liu, Kelly A Devereaux, et al.
Journal for Immunotherapy of Cancer
|
June 13, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
Sujana Movva, Kenneth Seier, Martina Bradic, et al.
Nature Medicine
|
April 23, 2024
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Claire F Friedman, Beryl L Manning-Geist, Qin Zhou, et al.
Scientific Reports
|
October 17, 2020
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis
Xuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, et al.
Page
of 56